Breast Cancer Clinical Trials in United Kingdom

A listing of 45 Breast Cancer clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

United Kingdom

Breast Cancer

13 - 24 of 45

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

There are currently 45 active clinical trials seeking participants for Breast Cancer research studies. The states with the highest number of trials for Breast Cancer participants are .

A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer

NCT06112379

Recruiting

This is a Phase III, 2-arm, randomised, open-label, multicentre, global study assessing the efficacy and safety of neoadjuvant Dato-DXd plus durvalumab followed by adjuvant durvalumab with or without chemotherapy compared with neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab with or without chemotherapy in participants with previously untreated TNBC or hormone receptor-low/HER2-negative breast cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/18/2025

Locations: Research Site, Daphne, Alabama +355 locations

Research Site, Daphne, Alabama

Research Site, Goodyear, Arizona

Research Site, Phoenix, Arizona

Research Site, Tucson, Arizona

Research Site, Jonesboro, Arkansas

Research Site, Rogers, Arkansas

Research Site, Bakersfield, California

Research Site, Fullerton, California

Research Site, Irvine, California

Research Site, Los Angeles, California

Research Site, Newport Beach, California

Research Site, Orange, California

Research Site, Santa Barbara, California

Research Site, Santa Rosa, California

Research Site, Sylmar, California

Research Site, Torrance, California

Research Site, Van Nuys, California

Research Site, Aurora, Colorado

Research Site, Fort Collins, Colorado

Research Site, Longmont, Colorado

Research Site, Bridgeport, Connecticut

Research Site, New Haven, Connecticut

Research Site, Newark, Delaware

Research Site, Fort Myers, Florida

Research Site, Jacksonville, Florida

Research Site, Port Saint Lucie, Florida

Research Site, Saint Petersburg, Florida

Research Site, Tallahassee, Florida

Research Site, West Palm Beach, Florida

Research Site, Atlanta, Georgia

Research Site, Chicago Ridge, Illinois

Research Site, Dyer, Indiana

Research Site, Des Moines, Iowa

Research Site, Edgewood, Kentucky

Research Site, Louisville, Kentucky

Research Site, Baton Rouge, Louisiana

Research Site, Annapolis, Maryland

Research Site, Boston, Massachusetts

Research Site, Detroit, Michigan

Research Site, Grand Rapids, Michigan

Research Site, Traverse City, Michigan

Research Site, Burnsville, Minnesota

Research Site, Minneapolis, Minnesota

Research Site, Columbia, Missouri

Research Site, Saint Louis, Missouri

Research Site, Omaha, Nebraska

Research Site, Henderson, Nevada

Research Site, Camden, New Jersey

Research Site, East Brunswick, New Jersey

Research Site, New Brunswick, New Jersey

Research Site, Santa Fe, New Mexico

Research Site, Commack, New York

Research Site, New York, New York

Research Site, Charlotte, North Carolina

Research Site, Durham, North Carolina

Research Site, Winston-Salem, North Carolina

Research Site, Blue Ash, Ohio

Research Site, Canton, Ohio

Research Site, Eugene, Oregon

Research Site, Portland, Oregon

Research Site, Horsham, Pennsylvania

Research Site, Philadelphia, Pennsylvania

Research Site, Pittsburgh, Pennsylvania

Research Site, Providence, Rhode Island

Research Site, Chattanooga, Tennessee

Research Site, Nashville, Tennessee

Research Site, Austin, Texas

Research Site, Dallas, Texas

Research Site, El Paso, Texas

Research Site, Flower Mound, Texas

Research Site, Fort Worth, Texas

Research Site, Houston, Texas

Research Site, Irving, Texas

Research Site, San Antonio, Texas

Research Site, Webster, Texas

Research Site, Fairfax, Virginia

Research Site, Norfolk, Virginia

Research Site, Richmond, Virginia

Research Site, Roanoke, Virginia

Research Site, Winchester, Virginia

Research Site, Tacoma, Washington

Research Site, Madison, Wisconsin

Research Site, Darlinghurst, Not set

Research Site, East Melbourne, Not set

Research Site, Heidelberg, Not set

Research Site, Herston, Not set

Research Site, Nedlands, Not set

Research Site, Waratah, Not set

Research Site, Feldkirch, Not set

Research Site, Graz, Not set

Research Site, Innsbruck, Not set

Research Site, Linz, Not set

Research Site, Salzburg, Not set

Research Site, Antwerpen, Not set

Research Site, Brasschaat, Not set

Research Site, Charleroi, Not set

Research Site, Gent, Not set

Research Site, Leuven, Not set

Research Site, Libramont-Chevigny, Not set

Research Site, Brasilia, Not set

Research Site, Curitiba, Not set

Research Site, Fortaleza, Not set

Research Site, Londrina, Not set

Research Site, Natal, Not set

Research Site, Porto Alegre, Not set

Research Site, Ribeirão Preto, Not set

Research Site, Santo Andre, Not set

Research Site, São Paulo, Not set

Research Site, Taubaté, Not set

Research Site, Vitória, Not set

Research Site, Plovdiv, Not set

Research Site, Shumen, Not set

Research Site, Sofia, Not set

Research Site, Vratza, Not set

Research Site, Calgary, Alberta

Research Site, Abbotsford, British Columbia

Research Site, Vancouver, British Columbia

Research Site, St. John's, Newfoundland and Labrador

Research Site, Barrie, Ontario

Research Site, London, Ontario

Research Site, Oshawa, Ontario

Research Site, Toronto, Ontario

Research Site, Levis, Quebec

Research Site, Montreal, Quebec

Research Site, Sherbrooke, Quebec

Research Site, St-Jerome, Quebec

Research Site, Saskatoon, Saskatchewan

Research Site, Montreal, Not set

Research Site, Ottawa, Not set

Research Site, Beijing, Not set

Research Site, Bengbu, Not set

Research Site, Changchun, Not set

Research Site, Changsha, Not set

Research Site, Chengdu, Not set

Research Site, Chongqing, Not set

Research Site, Guangzhou, Not set

Research Site, Hangzhou, Not set

Research Site, Harbin, Not set

Research Site, Hefei, Not set

Research Site, Jinan, Not set

Research Site, Kunming, Not set

Research Site, Linhai, Not set

Research Site, Nanchang, Not set

Research Site, Nanjing, Not set

Research Site, Nanning, Not set

Research Site, Shanghai, Not set

Research Site, Shenyang, Not set

Research Site, Shijiazhuang, Not set

Research Site, Suining, Not set

Research Site, Suzhou, Not set

Research Site, Tianjin, Not set

Research Site, Urumqi, Not set

Research Site, Wuhan, Not set

Research Site, Xi'an, Not set

Research Site, Xintai, Not set

Research Site, Zhaoqing, Not set

Research Site, Zhengzhou, Not set

Research Site, Avignon, Not set

Research Site, Bayonne, Not set

Research Site, Caen Cedex 5, Not set

Research Site, Clermont Ferrand, Not set

Research Site, Limoges, Not set

Research Site, Lyon, Not set

Research Site, Marseille, Not set

Research Site, Montpellier, Not set

Research Site, Nice, Not set

Research Site, Paris, Not set

Research Site, Reims Cedex, Not set

Research Site, Saint Herblain, Not set

Research Site, Toulouse, Not set

Research Site, Vandoeuvre les Nancy, Not set

Research Site, Villejuif Cedex, Not set

Research Site, Augsburg, Not set

Research Site, Berlin, Not set

Research Site, Dessau-Roßlau, Not set

Research Site, Dresden, Not set

Research Site, Erlangen, Not set

Research Site, Essen, Not set

Research Site, Esslingen am Neckar, Not set

Research Site, Frankfurt am Main, Not set

Research Site, Freiburg, Not set

Research Site, Hamburg, Not set

Research Site, Hannover, Not set

Research Site, Heidelberg, Not set

Research Site, Kiel, Not set

Research Site, Mainz, Not set

Research Site, Mannheim, Not set

Research Site, München, Not set

Research Site, Münster, Not set

Research Site, Trier, Not set

Research Site, Ulm, Not set

Research Site, Hong Kong, Not set

Research Site, Kwai Chung, Not set

Research Site, Budapest, Not set

Research Site, Kecskemét, Not set

Research Site, Miskolc, Not set

Research Site, Nyíregyháza, Not set

Research Site, Salgótarján, Not set

Research Site, Szekszárd, Not set

Research Site, Bengaluru, Not set

Research Site, Dehradun, Not set

Research Site, Delhi, Not set

Research Site, Kolkata, Not set

Research Site, Marg Jaipur, Not set

Research Site, Nagpur, Not set

Research Site, Nashik, Not set

Research Site, Puducherry, Not set

Research Site, Thiruvananthapuram, Not set

Research Site, Vadodara, Not set

Research Site, Empoli, Not set

Research Site, Lucca, Not set

Research Site, Macerata, Not set

Research Site, Milano, Not set

Research Site, Modena, Not set

Research Site, Napoli, Not set

Research Site, Padova, Not set

Research Site, Roma, Not set

Research Site, Rozzano, Not set

Research Site, Torino, Not set

Research Site, Tricase, Not set

Research Site, Udine, Not set

Research Site, Akashi-shi, Not set

Research Site, Akita-shi, Not set

Research Site, Bunkyo-ku, Not set

Research Site, Chiba-shi, Not set

Research Site, Chuo-ku, Not set

Research Site, Fukuoka-shi, Not set

Research Site, Fukushima-shi, Not set

Research Site, Gifu-shi, Not set

Research Site, Hidaka-shi, Not set

Research Site, Hirakata-shi, Not set

Research Site, Hiroshima-shi, Not set

Research Site, Isehara-shi, Not set

Research Site, Kashiwa, Not set

Research Site, Koto-ku, Not set

Research Site, Kumamoto-shi, Not set

Research Site, Kurume-shi, Not set

Research Site, Kyoto-shi, Not set

Research Site, Matsuyama-shi, Not set

Research Site, Nagoya-shi, Not set

Research Site, Niigata-shi, Not set

Research Site, Okayama, Not set

Research Site, Osaka-shi, Not set

Research Site, Sapporo-shi, Not set

Research Site, Sendai-shi, Not set

Research Site, Shinagawa-ku, Not set

Research Site, Shinjuku-ku, Not set

Research Site, Sunto-gun, Not set

Research Site, Tsu-shi, Not set

Research Site, Yokohama-shi, Not set

Research Site, Daegu, Not set

Research Site, Goyang-si, Not set

Research Site, Seongnam, Not set

Research Site, Seoul, Not set

Research Site, George Town, Not set

Research Site, Kuala Lumpur, Not set

Research Site, Kuching, Not set

Research Site, Selangor, Not set

Research Site, Bialystok, Not set

Research Site, Bydgoszcz, Not set

Research Site, Gdańsk, Not set

Research Site, Gdynia, Not set

Research Site, Kraków, Not set

Research Site, Tomaszów Mazowiecki, Not set

Research Site, Warszawa, Not set

Research Site, Wroclaw, Not set

Research Site, Łódź, Not set

Research Site, Singapore, Not set

Research Site, Barcelona, Not set

Research Site, Granada, Not set

Research Site, Hospitalet deLlobregat, Not set

Research Site, Madrid, Not set

Research Site, Santiago de Compostela, Not set

Research Site, Sevilla, Not set

Research Site, Zaragoza, Not set

Research Site, Baden, Not set

Research Site, Basel, Not set

Research Site, Bern, Not set

Research Site, Frauenfeld, Not set

Research Site, Genolier, Not set

Research Site, Rennaz, Not set

Research Site, Changhua, Not set

Research Site, Kaohsiung, Not set

Research Site, Taichung, Not set

Research Site, Tainan, Not set

Research Site, Taipei, Not set

Research Site, Taoyuan, Not set

Research Site, Bangkok, Not set

Research Site, Dusit, Not set

Research Site, Muang, Not set

Research Site, Songkhla, Not set

Research Site, Adapazari, Not set

Research Site, Ankara, Not set

Research Site, Istanbul, Not set

Research Site, Kayseri, Not set

Research Site, Samsun, Not set

Research Site, Birmingham, Not set

Research Site, Cardiff, Not set

Research Site, Edinburgh, Not set

Research Site, Guildford, Not set

Research Site, Lancaster, Not set

Research Site, London, Not set

Research Site, Northampton, Not set

Research Site, Oxford, Not set

Research Site, Taunton, Not set

Research Site, Hanoi, Not set

Research Site, Ho Chi Minh city, Not set

Research Site, Vinh, Not set

Conditions: Breast Cancer

Learn More ›

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

NCT06686394

Recruiting

Researchers want to learn if patritumab deruxtecan (MK-1022) can treat certain breast cancers. The breast cancers being studied are HER2 positive unresectable locally advanced or metastatic (the cancer has spread to other parts of the body). The goals of this study are to learn: * About the safety and how well people tolerate of patritumab deruxtecan * How many people have the cancer respond (get smaller or go away) to treatment

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/18/2025

Locations: Dana-Farber Cancer Institute ( Site 0050), Boston, Massachusetts +10 locations

Conditions: Breast Neoplasms, Breast Cancer

Learn More ›

Feasibility Study to Evaluate the Use of Patient Reported Complications After Digital Consent

NCT06351865

Recruiting

Patient report complication data to our best knowledge has not been studied yet in electronic consent. This study is a feasibility study to assess whether patients will reliably report their complications, the quality of this reporting and whether the information provided in the consent form matches up to their experience. This data will then be used to improve the consent process and evaluate whether the Patient Initiated Follow Up (PIFU) model is effective or if it leads to underreporting of p... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

07/14/2025

Locations: Queen Alexandra Hospital, Portsmouth, Hampshire

Conditions: Breast Cancer, Complication of Surgical Procedure

Learn More ›

Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial

NCT05072314

Recruiting

The LOLIPOP Trial is a large (n=4,300 patients) pragmatic, international, multicentre, prospective, randomised, double blind, placebo-controlled, parallel assessment, safety and effectiveness superiority study.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

07/03/2025

Locations: Blacktown Mount Druitt Hospital, Mount Druitt, New South Wales +38 locations

Blacktown Mount Druitt Hospital, Mount Druitt, New South Wales

Royal North Shore Hospital, Sydney, New South Wales

Westmead Hospital, Sydney, New South Wales

St George Hospital, Sydney, New South Wales

Royal Brisbane and Women's Hospital, Brisbane, Queensland

Queen Elizabeth II Jubilee Hospital, Coopers Plains, Queensland

Mackay Base Hospital, Mackay, Queensland

Rockhampton Hospital, Rockhampton, Queensland

Gold Coast Hospital and Health Service- Gold Coast University Hospital, Southport, Queensland

Princess Alexandra Hospital, Woolloongabba, Queensland

Flinders Medical Centre, Bedford Park, South Australia

Royal Hobart Hospital, Hobart, Tasmania

Anaesthetic Group Ballarat, Ballarat, Victoria

Ballarat Health Services (Grampians Health), Ballarat, Victoria

Barwon Health - University Hospital Geelong, Geelong, Victoria

The Alfred, Melbourne, Victoria

Royal Melbourne Hospital, Melbourne, Victoria

St Vincent's Hospital Melbourne, Melbourne, Victoria

Northern Hospital, Melbourne, Victoria

Monash Health - Moorabbin Hospital, Melbourne, Victoria

Maroondah Hospital - Eastern Health, Ringwood East, Victoria

Goulburn Valley Health, Shepparton, Victoria

Latrobe Regional Hospital, Traralgon, Victoria

Royal Perth Hospital, Perth, Western Australia

St John of God Subiaco, Perth, Western Australia

Pamela Youde Nethersole Eastern Hospital, Chai Wan, Not set

North District Hospital, Sha Tin, Not set

Ruttonjee Hospital, Wan Chai, Not set

Middlemore Hospital, Auckland, Middlemore

Waikato Hospital, Hamilton, Waikato

Auckland City Hospital, Auckland, Not set

University Hospital Wishaw, Wishaw, Scotland

Southmead Hospital, North Bristol Trust, Bristol, Not set

Darlington Memorial Hospital, Darlington, Not set

Royal Liverpool and Broadgreen Hospitals, Liverpool, Not set

Rotherham NHS Foundation Trust, Rotherham, Not set

St Helen's Hospital, Saint Helens, Not set

University Hospital Southampton, Southampton, Not set

Torbay Hospital, Torquay, Not set

Conditions: Breast Cancer, Breast Cancer Female, Breast Conserving Surgery, Mastectomy

Learn More ›

A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.

NCT06247995

Recruiting

In the phase I part, to determine the recommended doses (RD) and dosing regimens of \[177Lu\]Lu-NeoB in combination with capecitabine in adult patients with gastrin releasing peptide receptor positive, estrogen receptor-positive, human epidermal growth factor receptor-2 negative metastatic breast cancer after progression on previous endocrine therapy in combination with a CDK4/6 inhibitor. In the phase II part, to evaluate the preliminary anti-tumor activity of two different doses/regimens of \[... Read More

Gender:

ALL

Ages:

Between 18 years and 100 years

Trial Updated:

07/02/2025

Locations: UCLA Medical Center, Los Angeles, California +29 locations

UCLA Medical Center, Los Angeles, California

Hoag Memorial Hospital Presbyterian, Newport Beach, California

Mayo Clinic - Rochester, Rochester, Minnesota

Uni Of TX MD Anderson Cancer Cntr, Houston, Texas

University Of Wisconsin, Madison, Wisconsin

Novartis Investigative Site, Darlinghurst, New South Wales

Novartis Investigative Site, Malvern, Victoria

Novartis Investigative Site, Toronto, Ontario

Novartis Investigative Site, Montreal, Quebec

Novartis Investigative Site, Guangzhou, Not set

Novartis Investigative Site, Tianjin, Not set

Novartis Investigative Site, Bordeaux, Not set

Novartis Investigative Site, Grenoble, Not set

Novartis Investigative Site, Saint Herblain, Not set

Novartis Investigative Site, Strasbourg, Not set

Novartis Investigative Site, Villejuif, Not set

Novartis Investigative Site, Erlangen, Not set

Novartis Investigative Site, Essen, Not set

Novartis Investigative Site, Tuebingen, Not set

Novartis Investigative Site, Meldola, FC

Novartis Investigative Site, Reggio Emilia, RE

Novartis Investigative Site, Seoul, Not set

Novartis Investigative Site, Porto, Not set

Novartis Investigative Site, Singapore, Not set

Novartis Investigative Site, Sevilla, Andalucia

Novartis Investigative Site, Barcelona, Catalunya

Novartis Investigative Site, Hospitalet de LLobregat, Catalunya

Novartis Investigative Site, Madrid, Not set

Novartis Investigative Site, London, Not set

Conditions: Breast Cancer

Learn More ›

Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)

NCT05501886

Recruiting

This is a Phase 3, open-label, randomized, clinical trial evaluating the efficacy and safety of gedatolisib plus fulvestrant with or without palbociclib for the treatment of patients with locally advanced or metastatic HR+/HER2- breast cancer following progression on or after CDK4/6 and aromatase inhibitor therapy.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/23/2025

Locations: University of Alabama at Birmingham, Birmingham, Alabama +216 locations

University of Alabama at Birmingham, Birmingham, Alabama

Arizona Oncology (US Oncology/McKesson) - Goodyear, Goodyear, Arizona

St. Bernards Medical Center, Jonesboro, Arkansas

CARTI Cancer Center, Little Rock, Arkansas

Pacific Cancer Medical Center Inc, Anaheim, California

Kaiser Permanente South Bay Medical Center, Harbor City, California

Cancer and Blood Specialty Clinic, Los Alamitos, California

Pacific Cancer Care, Monterey, California

University of California, Irvine Medical Center, Orange, California

Ventura County Hematology Oncology Specialists, Oxnard, California

Redlands Hematology Oncology, Redlands, California

UCLA Hematology/Oncology-Santa Monica, Santa Monica, California

Torrance Memorial Physician Network - Cancer Care, Torrance, California

Kaiser Permanente Medical Center - Vallejo, Vallejo, California

PIH Health Hospital Whittier, Whittier, California

Yale Cancer Center - New Haven, New Haven, Connecticut

South Broward Hospital District d/b/a Memorial Healthcare System, Hollywood, Florida

Cancer Specialists of North Florida - Jacksonville, Jacksonville, Florida

H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida

Bond & Steele Clinic, P.A. d/b/a Bond Clinic, P.A., Winter Haven, Florida

John D. Archbold Memorial Hospital, Thomasville, Georgia

Illinois Cancer Specialists - Arlington Heights, Arlington Heights, Illinois

Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana

University of Kentucky Medical Center, Lexington, Kentucky

Mercy Health - Paducah, Paducah, Kentucky

American Oncology Partners of Maryland, PA, Bethesda, Maryland

Maryland Oncology Hematology, P.A. - Rockville, Rockville, Maryland

Dana Farber Cancer Institute, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Henry Ford Hospital, Detroit, Michigan

Nebraska Hematology - Oncology, P.C., Lincoln, Nebraska

Oncology Hematology West PC dba Nebraska Cancer Specialists, Omaha, Nebraska

University of Nebraska Medical Center, Omaha, Nebraska

New York Oncology Hematology, P.C. - Albany, Albany, New York

Montefiore Medical Center, Bronx, New York

Queens Hospital Cancer Center, Jamaica, New York

Coleman, Pasmantier & Decter, MDs, New York, New York

Weill Cornell Medicine/New York-Presbyterian Hospital, New York, New York

University of Rochester Medical Center, Rochester, New York

Hematology/Oncology Associates of Central New York, Syracuse, New York

White Plains Hospital, White Plains, New York

Cone Health Cancer Center at Alamance Regional, Hematology/Oncology, Greensboro, North Carolina

Southeast Regional Cancer Center, Lumberton, North Carolina

University Hospitals Cleveland Medical Center, Cleveland, Ohio

The James Cancer Hospital and Solove Research Institute, Columbus, Ohio

OU Health Stephenson Cancer Center, Oklahoma City, Oklahoma

Oregon Oncology Specialists, Salem, Oregon

Northwest Cancer Specialists, PC - Tigard, Tigard, Oregon

Consultants In Medical Oncology and Hematology, P.C., Broomall, Pennsylvania

Alliance Cancer Specialists PC, Horsham, Pennsylvania

Cancer Care Associates of York, York, Pennsylvania

Sanford Gynecologic Oncology Clinic, Sioux Falls, South Dakota

Texas Oncology - Austin, Austin, Texas

Texas Oncology P.A. - Dallas, Dallas, Texas

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas

William Beaumont Army Medical Center, El Paso, Texas

Oncology Consultants, Houston, Texas

University of Texas MD Anderson Cancer Center, Houston, Texas

Brooke Army Medical Center, Houston, Texas

Texas Oncology - McKinney, McKinney, Texas

Texas Oncology - Gulf Coast, Sugar Land, Texas

Texas Oncology - Tyler, Tyler, Texas

Fort Belvoir Community Hospital, Fort Belvoir, Virginia

Bon Secours St. Francis Medical Oncology Center, Midlothian, Virginia

Virginia Oncology Associates - Newport News, Newport News, Virginia

VCU Massey Cancer Center, Richmond, Virginia

Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care - Roanoke, Roanoke, Virginia

Fred Hutchinson Cancer Center, Seattle, Washington

Northwest Medical Specialties, PLLC - Tacoma, Tacoma, Washington

Alexander Fleming Institute, Buenos Aires, Not set

Buenos Aires British Hospital, Buenos Aires, Not set

CENIT Foundation, Buenos Aires, Not set

Center for Medical Education and Clinical Research (CEMIC), Buenos Aires, Not set

Fleischer Medical Center, Buenos Aires, Not set

Medical Center Austral, Buenos Aires, Not set

Pergamino Clinic, Buenos Aires, Not set

Cordoba Oncology Institute (IONC), Córdoba, Not set

Center of Nuclear and Molecular Medicine of Entre Rios (CEMENER), Paraná, Not set

CEDIT Diagnostic and treatment center, Salta, Not set

CER San Juan, San Juan, Not set

Rosario's Oncology Institute and Medical Specialities (IOR), Santa Fe, Not set

9 of July Sanatorium, Tucumán, Not set

Adelaide Oncology & Haematology, Adelaide, Not set

St Vincent's Hospital (Melbourne) Ltd, Fitzroy, Not set

Peninsula & South Eastern Hematology and Oncology Group (PSEHOG), Frankston, Not set

Hollywood Private Hospital, Breast Cancer Research Centre, Nedlands, Not set

Mater Hospital Brisbane, Mater Cancer Care Centre, South Brisbane, Not set

Icon Cancer Centre- Southport, Southport, Not set

Sydney Adventist Hospital, Wahroonga, Not set

The Queen Elizabeth Hospital, Woodville, Not set

University Hospital Graz, Department of Gynecology and Obstetrics, Graz, Not set

University Hospital Innsbruck - Tyrolean Hospital, Department of Gynaecology and Obstetrics, Innsbruck, Not set

Order Hospital Linz Ltd. - Hospital of Sisters of Mercy, Department of Internal Medicine I, Linz, Not set

Salzburg Regional Hospital, Department of Internal Medicine III, Salzburg, Not set

University Hospital St. Poelten, Department of Internal Medicine I, St. Poelten, Not set

Hospital Hietzing, Department of Gynecology, Vienna, Not set

Medical University Vienna, Department of Gynecology and Obstetrics, Vienna, Not set

Saint Luc University Hospital, Brussels, Not set

Charleroi Grand Hospital (GHDC), Charleroi, Not set

University Hospital Antwerp (UZA), Edegem, Not set

AZ Groeninge, Kortrijk, Not set

University Hospitals Leuven, Campus Gasthuisberg, Leuven, Not set

Citadelle Regional Hospital Center, Liège, Not set

VITAZ, Sint-Niklaas, Not set

Centre Hospitalier Peltzer-la-Tourelle, Verviers, Not set

UCL Mont-Godinne University Hospitals, Yvoir, Not set

Oncology Treatment Center, Belém, Pará

Pronutrir, Fortaleza, Not set

ONCOSITE - Clinical Research Center in Oncology, Ijuí, Not set

Juiz de Fora Eurolatino Research Center, Minas Gerais, Not set

Bahia Oncology Center, Salvador de Bahia, Not set

D'OR Institute, São Paulo, Not set

Hospital A.C.Camargo, São Paulo, Not set

Multiprofile Hospital for Active Treatment - Uni Hospital, Panagyurishte, Panagyurishte, Not set

MHAT for Women's Health "Nadezhda", Sofia, Not set

Multiprofile Hospital for Active Treatment "Serdika", Sofia, Sofia, Not set

Specialized Hospital for Active Treatment in Oncology, Clinic of Medicial Oncology (Chemotherapy), Sofia, Not set

University Multiprofile Hospital for Active Treatment "Sveta Marina", Varna, Not set

BC Cancer - Vancouver, Medical Oncology, Vancouver, British Columbia

CIUSSS du Saguenay Lac St-Jean, Chicoutimi, Quebec

Hospital Notre-Dame, Montréal, Quebec

Maisonneuve-Rosemont Hospital, Montréal, Quebec

University Hospital Olomouc, Clinic of Oncology, Olomouc, Not set

Thomayer University Hospital, Clinic of Oncology, Prague, Not set

University Hospital Bulovka, Institute of Radiation Oncology, Prague, Not set

University Hospital Motol, Clinic of Oncology, Prague, Not set

Bergonie Institute, Bordeaux, Not set

Francois Baclesse Center, Caen, Not set

La Roche-sur-Yon Hospital, La Roche-sur-Yon, Not set

CHU La Timone - La Timone Children's Hospital, Marseille, Not set

University Hospital Center of Poitiers, Poitiers, Not set

Saint Anne Clinic, Strasbourg, Not set

Gustave Roussy, Villejuif, Not set

Hospital Bayreuth, Bayreuth, Not set

Vivantes Hospital Am Urban, Berlin, Not set

Private Practice with Focus on Oncology, Luebeck, Not set

University Hospital Johannes Gutenberg - University of Mainz, Mainz, Not set

Hospital Suedstadt Rostock, Mecklenburg, Not set

University Hospital Muenster, Münster, Not set

Caritas Klinikum, Saarbrücken, Not set

Helios Clinic Wuppertal, Wuppertal, Not set

Alexandra General Hospital, Athens, Not set

University General Hospital of Ioannina, Ioánnina, Not set

IASO Thessaly SA, Larissa, Not set

EUROMEDICA General Clinic of Thessaloniki, Thessaloníki, Not set

Theageneio Anticancer Hospital of Thessaloniki, Thessaloníki, Not set

University of Debrecen Clinical Center, Institute of Oncology, Debrecen, Not set

Bacs-Kiskun County Hospital, Center for Oncoradiology, Kecskemét, Not set

Szabolcs-Szatmar-Bereg County Hospitals and University Teaching Hospital, Department of Oncology, Nyíregyháza, Not set

HCG Cancer Centre, Bangalore, Not set

Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, Not set

Tata Medical Center, Kolkata, Not set

Tata Memorial Hospital, Navi Mumbai, Not set

Christian Medical College, Department of Medical Oncology, Vellore, Not set

European Institute of Oncology (IEO), IRCCS, Milan, Not set

University Polyclinic Hospital of Modena, Modena, Not set

Local Healthcare Company of Monza (ASST Monza), Monza, Not set

University Hospital of Parma, Parma, Not set

New Hospital of Prato (NOP), Prato, Not set

University Hospital Campus Bio-Medico, Rome, Not set

University Polyclinic Foundation "Agostino Gemelli" - IRCCS, Rome, Not set

Santa Maria della Misericordia University Hospital of Udine, Udine, Not set

Asan Medical Center, Seoul, Not set

Gangnam Severance Hospital, Soeul, Not set

Korea University Anam Hospital, Soeul, Not set

Samsung Medical Center, Soeul, Not set

Severance Hospital, Yonsei University Health System, Soeul, Not set

Ulsan University Hospital, Ulsan, Not set

Clinical Research Center Chapultepec Mexico City, Mexico City, Not set

CRYPTEX, Mexico City, Not set

ProcliniQ Clinical Research, Mexico City, Not set

Filios High Medicine, Monterrey, Not set

Administrative Society of Health Services, SC, Morelia, Not set

Avix Clinical Research, Nuevo León, Not set

Zambrano Hellion Medical Center, Nuevo León, Not set

Inbiomedyc, Querétaro, Not set

ONCOR Life Medical Center, Saltillo, Not set

Prof. Franciszek Lukaszczyk Oncology Center in Bydgoszcz, Chemotherapy Outpatient Clinic, Bydgoszcz, Not set

Medical Clinic "Komed", Konin, Not set

Maria Sklodowska-Curie Institute of Oncology, Branch in Krakow, Kraków, Not set

Independent Public Healthcare Facility Prof. Tadeusz Koszarowski Opole Oncology Center in Opole, Clinical Oncology Department and Day Hospitalization Unit, Opole, Not set

St. John Paul 2nd Mazovian Provincial Hospital in Siedlce Limited Liability Company, Siedlce Oncology Centre, Siedlce, Not set

West Pomeranian Oncology Center, Szczecin, Not set

LUX MED Oncology LLC, Szamocka Hospital, Department of Clinical Oncology/Chemotherapy, Warsaw, Not set

Maria Sklodowska-Curie - National Research Institute of Oncology, Warsaw, Not set

Provincial Specialist Hospital in Wroclaw, Department of Chemotherapy, Wroclaw, Not set

Polish Mother's Memorial Hospital-Research Institute, Łódź, Not set

S.C. Oncopremium-Team SRL, Baia Mare, Not set

Prof. Dr. Alexandru Trestioreanu Institute of Oncology, Bucharest, Not set

Prof. Dr. Ion Chiricuta Institute of Oncology, Cluj-Napoca, Not set

Onco Clinic Consult S.A., Craiova, Not set

Oncology Center "Sf. Nectarie", Craiova, Not set

S.C. Topmed Medical Center SRL, Târgu-Mureş, Not set

Curie Oncology, Singapore, Not set

ICON SOC Farrer Park Medical Clinic, Singapore, Not set

OncoCare Cancer Centre, Singapore, Not set

Raffles Hospital, Singapore, Not set

Tan Tock Seng Hospital, Singapore, Not set

Infanta Cristina Hospital, Badajoz, Not set

Catalan Institute of Oncology, Hospital Duran i Reynals, Barcelona, Not set

Caceres Hospital Complex - San Pedro de Alcantara General Hospital, Cáceres, Not set

Hospital Ruber Internacional, Madrid, Not set

University Hospital Foundation Jimenez Diaz, Madrid, Not set

University Clinical Hospital Virgen de la Arrixaca, Department of Oncology, Murcia, Not set

University Hospital Complex of Santiago (CHUS), Department of Oncology, Santiago De Compostela, Not set

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Not set

Taipei Medical University - Shuang Ho Hospital, New Taipei City, Not set

China Medical University Hospital, Taichung, Not set

National Cheng Kung University Hospital, Tainan, Not set

National Taiwan University Hospital, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Royal United Hospital, Department of Oncology/Hematology, Bath, Not set

Velindre Cancer Centre, Cardiff, Not set

Guy's Hospital, London, Not set

Royal Marsden Hospital - London, Department of Medical Oncology, London, Not set

The Christie NHS Foundation Trust, Manchester, Not set

Nottingham City Hospital, Nottingham, Not set

Conditions: Breast Cancer

Learn More ›

Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

NCT06760637

Recruiting

The purpose of this study is to determine the safety and efficacy of PF-07220060 with letrozole compared to approved treatments (ie, palbociclib, ribociclib or abemaciclib with letrozole) in people with breast cancer: * HR-positive (breast cancer cells that need estrogen or progesterone to grow) * HER2-negative (cells that have a small amount or none of a protein called HER2 on their surface); * locally advanced (that has spread from where it started to nearby tissue or lymph nodes) or metastat... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/17/2025

Locations: Ironwood Cancer & Research Centers, Chandler, Arizona +254 locations

Ironwood Cancer & Research Centers, Chandler, Arizona

Ironwood Cancer & Research Centers, Gilbert, Arizona

Ironwood Cancer & Research Centers, Glendale, Arizona

Ironwood Cancer & Research Centers, Mesa, Arizona

Ironwood Cancer & Research Centers, Phoenix, Arizona

Ironwood Cancer & Research Centers, Scottsdale, Arizona

Highlands Oncology, Fayetteville, Arkansas

Highlands Oncology, Rogers, Arkansas

Highlands Oncology Group, Springdale, Arkansas

Cancer and Blood Specialty Clinic / Cancer and Blood Research Center, LLC, Los Alamitos, California

Keck Hospital of USC, Los Angeles, California

Los Angeles General Medical Center, Los Angeles, California

Norris Healthcare Center 3 (HC3), Los Angeles, California

USC/Norris Comprehensive Cancer Center, Los Angeles, California

Keck Medicine of USC Norris Oncology/Hematology - Newport Beach Treatment Center, Newport Beach, California

USC Norris Oncology/Hematology - Newport Beach, Newport Beach, California

Keck Medical Center of USC Pasadena, Pasadena, California

Wellness Oncology Hematology, West Hills, California

Intermountain Health St. Joseph Hospital, Denver, Colorado

Saint Joseph Hospital - Cancer Centers of Colorado, Denver, Colorado

Intermountain Health Lutheran Hospital, Golden, Colorado

Lutheran Hospital - Cancer Centers of Colorado, Golden, Colorado

Cancer Centers of Colorado St. Mary's Regional Hospital, Grand Junction, Colorado

Intermountain Health Saint Mary's Regional Hospital, Grand Junction, Colorado

Intermountain Health, Grand Junction, Colorado

MedStar Washington Hospital Center, Washington, District of Columbia

AdventHealth Altamonte Infusion Center, Altamonte Springs, Florida

AdventHealth Altamonte Springs, Altamonte Springs, Florida

AdventHealth Medical Group Altamonte, Altamonte Springs, Florida

Mount Sinai Medical Center, Aventura, Aventura, Florida

Boca Raton Regional Hospital, Boca Raton, Florida

Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida

Mount Sinai Medical Center, Miami Beach, Florida

Mid Florida Hematology and Oncology Center, Orange City, Florida

AdventHealth Orlando, Orlando, Florida

AdventHealth Medical Group Orlando, Orlando, Florida

AdventHealth Orlando Infusion Center, Orlando, Florida

Summit Cancer Care, PC, Savannah, Georgia

St. Luke's Cancer Institute: Boise, Boise, Idaho

St. Luke's Regional Medical Center, Boise, Idaho

St. Luke's Cancer Institute-Fruitland, Fruitland, Idaho

St. Luke's Cancer Institute-Meridian, Meridian, Idaho

St. Lukes Meridian Medical Center, Meridian, Idaho

St. Luke's Cancer Institute-Nampa, Nampa, Idaho

Endeavor Health, Elmhurst, Illinois

Ascension Illinois - Evanston Infusion Center, Evanston, Illinois

Hope and Healing Cancer Services, Hinsdale, Illinois

Endeavor Health, Naperville, Illinois

Hope and Healing Cancer Services, New Lenox, Illinois

Ascension Illinois-Skokie Infusion Center, Skokie, Illinois

Orchard Healthcare Research Inc., Skokie, Illinois

Velocity Clinical Research, Annapolis, Maryland

Mercy Medical Center - Baltimore, Baltimore, Maryland

Brigham and Women's Hospital, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Dana-Farber Cancer Institute, Boston, Massachusetts

Dana-Farber Cancer Institute - Chestnut Hill, Newton, Massachusetts

Allina Health Cancer Institute - Mercy Hospital, Coon Rapids, Minnesota

Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis, Minnesota

Allina Health Cancer Institute - United Hospital, Saint Paul, Minnesota

Saint Luke's Cancer Institute, Kansas City, Missouri

Bozeman Health Deaconess Hospital, Bozeman, Montana

Renown Health, Reno, Nevada

Renown Regional Medical Center, Reno, Nevada

Providence Cancer Institute Franz Clinic, Portland, Oregon

Providence Portland Medical Center Investigational Drug Services, Portland, Oregon

Providence Portland Medical Center, Portland, Oregon

Providence Investigational Drug Service - Westside, Portland, Oregon

Providence Oncology and Hematology Care Clinic - Westside, Portland, Oregon

Providence St. Vincent Medical Center, Portland, Oregon

The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center, Tyler, Texas

The University of Texas Health Science Center at Tyler on behalf of UT Health East Texas HOPE Cancer, Tyler, Texas

Utah Cancer Specialists, Bountiful, Utah

Utah Cancer Specialists, Layton, Utah

Utah Cancer Specialists, Murray, Utah

Utah Cancer Specialists, Ogden, Utah

Utah Cancer Specialists, Orem, Utah

Utah Cancer Specialists, Pleasant Grove, Utah

Utah Cancer Specialists, Provo, Utah

Utah Cancer Specialists, Salt Lake City, Utah

Utah Cancer Specialists, West Jordan, Utah

Utah Cancer Specialists, West Valley City, Utah

Townsville University Hospital, Douglas, Queensland

Princess Alexandra Hospital, Woolloongabba, Queensland

Rosebud Hospital, Capel Sound, Victoria

Frankston Hospital, Frankston, Victoria

Peter MacCallum Cancer Centre, Melbourne, Victoria

Royal Melbourne Hospital, Parkville, Victoria

Grand Hôpital de Charleroi, Gilly, Hainaut

AZ Maria Middelares, Gent, Oost-vlaanderen

UZ Leuven, Leuven, Vlaams-brabant

AZORG Campus Aalst-Moorselbaan, Aalst, Not set

Multiprofile Hospital for Active Treatment Serdika EOOD, Sofia, Sofia (stolitsa)

Complex Oncology Center - Burgas, Burgas, Not set

Multiprofile Hospital for Active Treatment Dr. Tota Venkova AD, Gabrovo, Not set

Specialized Hospital for Active Treatment of Oncology - Haskovo, Haskovo, Not set

Complex Oncology Center - Plovdiv EOOD, Plovdiv, Not set

Complex Oncology Center - Shumen, Shumen, Not set

MHAT for Women's Health Nadezhda, Sofia, Not set

Dr. Everett Chalmers Regional Hospital, Fredericton, New Brunswick

Princess Margaret Cancer Centre, Toronto, Ontario

Cancer Hospital Chinese Academy of Medical Science, Beijing, Beijing

Peking University People's Hospital, Beijing, Beijing

Beijing Cancer hospital, Beijing, Beijing

The First People's Hospital of Foshan, Foshan, Guangdong

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong

Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei

Hunan Cancer Hospital, Changsha, Hunan

Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu

The First Hospital of Jilin University, Changchun, Jilin

The 2nd Affiliated Hospital of Dalian Medical University, Dalian, Liaoning

The First Hospital of China Medical University, Shenyang, Liaoning

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi

Sir Run Run Shaw Hospital, Hangzhou, Zhejiang

Taizhou Hospital of Zhejiang Province, Linhai, Zhejiang

Fakultni Thomayerova nemocnice, Prague, Praha 4

Fakultni nemocnice v Motole, Praha, Praha 5

Nemocnice AGEL Novy Jicin a.s., Nový Jičín, Not set

Rigshospitalet, Copenhagen, Hovedstaden

Aarhus Universitetshospital, Skejby, Aarhus, Midtjylland

Aalborg Universitetshospital, Syd, Aalborg, Nordjylland

Esbjerg sygehus, Syddansk Universitetshospital, Esbjerg, Syddanmark

Sygehus Soenderjylland, Soenderborg, Syddanmark

Tampereen yliopistollinen sairaala, Tampere, Pirkanmaa

Vaasan Keskussairaala, Vaasa, Pohjanmaa

Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus), Helsinki, Uusimaa

Turku University Hospital, Turku, Varsinais-suomi

Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest, Bordeaux, Aquitaine

Centre Eugène Marquis Rennes - Centre de Lutte Contre le Cancer, Rennes, Ille-et-vilaine

Centre de Cancérologie du Grand Montpellier, Montpellier, Languedoc-roussillon

Institut de Cancérologie de l'Ouest, Saint Herblain, Loire-atlantique

Institut de Cancérologie de l'Ouest, ANGERS cedex 02, Maine-et-loire

Centre de Lutte Contre le Cancer - Centre Henri Becquerel Normandie Rouen, Rouen, Seine-maritime

CHD Vendee, La Roche-sur-Yon, Vendée

Centre Hospitalier de la Côte Basque, Bayonne, Not set

Henri Mondor Hospital, Créteil, Île-de-france

InVO Institut für Versorgungsforschung in der Onkologie, Koblenz, Rheinland-pfalz

Universitaetsklinikum Carl Gustav Carus Dresden, Dresden, Sachsen

Gemeinschaftspraxis Hämatologie - Onkologie Freiberg-Richter, Jacobasch, Illmer, Wolf, Dresden, Not set

Facharztzentrum Eppendorf, Hamburg, Not set

Agios Savvas Regional Cancer Hospital, Athens, Attikí

Hygeia Hospital, Marousi, Attikí

Aretaieio Hospital, Αθήνα, Attikí

Aretaieio Hospital, Athens, Not set

Heves Vármegyei Markhot Ferenc Oktatókórház és Rendelőintézet, Eger, Heves

Országos Onkológiai Intézet, Budapest, Not set

Rajiv Gandhi Cancer Institute And Research Centre, New Delhi, Delhi

Nirmal Hospital Pvt Ltd., Surat, Gujarat

Artemis hospital, Gurugram, Haryana

Spandana Oncology Centre (SOC), Bangalore, Karnataka

Tata Memorial Hospital, Mumbai, Maharashtra

Apex Wellness Hospital, Nashik, Maharashtra

Deenanath Mangeshkar Hospital & Research Centre, Pune, Maharashtra

Sahyadri Super Speciality Hospital, Pune, Maharashtra

Bhakti Vedanta Hospital and Research Institute, Thane, Maharashtra

Basavatarakam Indo American Cancer Hospital & Research Institute, Hyderabad, Telangana

Apollo Multispeciality Hospitals limited, Kolkata, WEST Bengal

Mater Misericordiae University Hospital, Dublin, Not set

Mater Private Hospital - Dublin, Dublin, Not set

Beaumont Hospital, Dublin, Dublin, Not set

Rabin Medical Center, Petah Tikva, Hamerkaz

Sheba Medical Center, Ramat Gan, Hamerkaz

Rambam Health Care Campus, Haifa, Hatsafon

Sourasky Medical Center, Tel Aviv, Tell Abīb

Hadassah Medical Center, Jerusalem, Yerushalayim

IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Emilia-romagna

Cro-Irccs, Aviano, Friuli-venezia Giulia

Istituto Nazionale Tumori Regina Elena, Rome, Roma

Azienda Ospedaliera Universitaria Careggi, Firenze, Toscana

Istituto Europeo di Oncologia IRCCS, Milano, Not set

Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Not set

Aichi Cancer Center, Nagoya, Aichi

Nagoya University Hospital, Nagoya, Aichi

Nagoya City University Hospital, Nagoya, Aichi

Gunma Prefectural Cancer Center, Otashi, Gunma

National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido

Kanagawa cancer center, Yokohama, Kanagawa

Kyoto University Hospital, Sakyo-ku, Kyoto

Tohoku University Hospital, Sendai, Miyagi

Osaka University Hospital, Suita, Osaka

Juntendo University Hospital, Bunkyo-ku, Tokyo

National Cancer Center Hospital, Chuo-ku, Tokyo

The Cancer Institute Hospital of JFCR, Koto-ku, Tokyo

Showa University Hospital, Shinagawa, Tokyo

National Center for Global Health and Medicine, Shinjuku City, Tokyo

Chiba Cancer Center, Chiba, Not set

National Hospital Organization Kyushu Cancer Center, Fukuoka, Not set

Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Not set

Kumamoto Shinto General Hospital, Kumamoto, Not set

Okayama University Hospital, Okayama, Not set

National Hospital Organization Osaka National Hospital, Osaka, Not set

Osaka International Cancer Institute, Osaka, Not set

Gachon University Gil Medical Center, Incheon, Incheon-gwangyeoksi [incheon]

Gangnam Severance Hospital, Yonsei University Health System, Gangnam-gu, Seoul-teukbyeolsi [seoul]

Korea University Anam Hospital, Seoul, Seoul-teukbyeolsi [seoul]

Asan Medical Center, Seoul, Seoul-teukbyeolsi [seoul]

Ewha Womans University Mokdong Hospital, Seoul, Seoul-teukbyeolsi [seoul]

Centrum Badań Klinicznych Jagiellońskie Centrum Innowacji sp. z o.o., Kraków, Małopolskie

Pratia MCM Krakow, Kraków, Małopolskie

AIDPORT Sp. z o.o., Skórzewo, Wielkopolskie

Europejskie Centrum Zdrowia Otwock Szpital im.F.Chopina, Otwock, Not set

Instytut MSF Sp zoo, Łódź, Łódzkie

Nemocnica s poliklinikou Stefana Kukuru Michalovce a.s., Michalovce, Košický KRAJ

Nemocnica AGEL Komarno, Komarno, Nitriansky KRAJ

Medeon, s.r.o., Banka, Trnavský KRAJ

Hospital General Universitario de Elche, Elche, Alicante

Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [barcelona]

Institut Català d'Oncologia - L'Hospitalet, Hospitalet, Barcelona [barcelona]

Hospital Clínic de Barcelona, Barcelona, Catalunya [cataluña]

Hospital Jerez de la Frontera, Jerez de la Frontera, Cádiz

Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad DE

Hospital Universitario Virgen de la Victoria, Malaga, Málaga

Osi Bilbao-Basurto, Bilbo, PAÍS Vasco

Hospital Universitario San Cecilio, Granada, Not set

Hospital Universitario HM Sanchinarro, Madrid, Not set

Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca, Salamanca, Not set

Hospital Universitario Virgen Macarena, Sevilla, Not set

Sjukhuset I Gävle, Gävle, Gävleborgs LÄN [se-21]

Södersjukhuset, Stockholm, Stockholms LÄN [se-01]

Akademiska sjukhuset, Uppsala, Uppsala LÄN [se-03]

Västmanlands Sjukhus Västerås, Västerås, Västmanlands LÄN [se-19]

Sahlgrenska Universitetssjukhuset, Gothenburg, Västra Götalands LÄN [se-14]

Lanssjukhuset Ryhov, Jönköping, Not set

Capio Saint Görans Sjukhus, Stockholm, Not set

Sundsvalls Sjukhus, Sundsvall, Not set

Tumor Zentrum Aarau, Aarau, Aargau

Inselspital Bern, Bern, Berne

Kantonsspital Frauenfeld - Spital Thurgau AG, Frauenfeld, Thurgau

Kantonsspital Baden, Baden, Not set

Kantonsspital Graubünden, Chur, Not set

Kantonsspital Münsterlingen - Spital Thurgau AG, Münsterlingen, Not set

Kantonsspital Olten, Olten, Not set

Kantonsspital Winterthur, Winterthur, Not set

National Taiwan University Hospital - Hsinchu branch, Zhu Bei City, Hsinchu

Taichung Veterans General Hospital, Taichung, Not set

National Cheng Kung University Hospital, Tainan, Not set

National Taiwan University Hospital, Taipei, Not set

Mackay Memorial Hospital, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Not set

Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Not set

Medipol Mega Universite Hastanesi, Istanbul, İ̇stanbul

İ.A.Ü VM Medical Park Florya Hastanesi, Istanbul, İ̇stanbul

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi, Istanbul, İ̇stanbul

Gulhane Egitim Arastirma Hastanesi, Ankara, Not set

Hacettepe Universite Hastaneleri, Ankara, Not set

Memorial Ankara Hastanesi, Ankara, Not set

Gazi University Health Research and Application Center Gazi Hospital, Ankara, Not set

Dicle Üniversitesi, Diyarbakir, Not set

Sakarya Training and Research Hospital, Sakarya, Not set

Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, Hammersmith AND Fulham

Sarah Cannon Research Institute UK, London, London, CITY OF

The Christie NHS Foundation Trust, Manchester, Not set

Conditions: Breast Cancer

Learn More ›

A Phase I/IIa Study of AZD8205 Given Alone or in Combination With Anticancer Drugs, in Participants With Advanced or Metastatic Solid Malignancies

NCT05123482

Recruiting

This research study is studying a new compound, AZD8205, as a possible treatment for advanced or metastatic solid tumours alone or in combination with anti-cancer agents

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/13/2025

Locations: Research Site, Duarte, California +65 locations

Research Site, Duarte, California

Research Site, Irvine, California

Research Site, Santa Monica, California

Research Site, Santa Rosa, California

Research Site, Sarasota, Florida

Research Site, Shreveport, Louisiana

Research Site, Baltimore, Maryland

Research Site, Boston, Massachusetts

Research Site, Saint Louis, Missouri

Research Site, Albuquerque, New Mexico

Research Site, Commack, New York

Research Site, New York, New York

Research Site, Charlotte, North Carolina

Research Site, Pittsburgh, Pennsylvania

Research Site, Houston, Texas

Research Site, Clayton, Not set

Research Site, Melbourne, Not set

Research Site, Nedlands, Not set

Research Site, South Brisbane, Not set

Research Site, Anderlecht, Not set

Research Site, Leuven, Not set

Research Site, Calgary, Alberta

Research Site, Vancouver, British Columbia

Research Site, Ottawa, Ontario

Research Site, Toronto, Ontario

Research Site, Montreal, Quebec

Research Site, Beijing, Not set

Research Site, Changsha, Not set

Research Site, Chongqing, Not set

Research Site, Guangzhou, Not set

Research Site, Kunming, Not set

Research Site, Shandong, Not set

Research Site, Budapest, Not set

Research Site, Milan, Not set

Research Site, Modena, Not set

Research Site, Roma, Not set

Research Site, Rozzano, Not set

Research Site, Chuo-ku, Not set

Research Site, Hidaka-shi, Not set

Research Site, Kashiwa, Not set

Research Site, Koto-ku, Not set

Research Site, Kurume-shi, Not set

Research Site, Sunto-gun, Not set

Research Site, Seoul, Not set

Research Site, Amsterdam, Not set

Research Site, Gdańsk, Not set

Research Site, Warszawa, Not set

Research Site, Barcelona, Not set

Research Site, L'Hospitalet de Llobregat, Not set

Research Site, Madrid, Not set

Research Site, Málaga, Not set

Research Site, Pamplona, Not set

Research Site, Tainan, Not set

Research Site, Taipei, Not set

Research Site, Taoyuan, Not set

Research Site, Bangkok, Not set

Research Site, Chiang Mai, Not set

Research Site, Cambridge, Not set

Research Site, Cardiff, Not set

Research Site, London, Not set

Conditions: Breast Cancer, Ovarian Cancer, Endometrial Cancer, Biliary Tract Carcinoma, Squamous Non-Small Cell Lung Cancer

Learn More ›

International Prospective REgistry on Pre-pectorAl Breast REconstruction

NCT05817175

Recruiting

This is an international multicenter prospective cohort study aimed at collecting data on breast reconstruction techniques with pre-pectoral implants after mastectomy for breast cancer. The aim of the study is to collect data on the surgical, aesthetic and oncological results, as well as on the quality of life of the patients who will undergo breast reconstruction with a pre-pectoral approach.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

06/03/2025

Locations: Univesidad de Buenos Aires, Buenos Aires, Not set +10 locations

Conditions: Breast Cancer

Learn More ›

OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

NCT06016738

Recruiting

This phase 3 clinical trial compares the safety and efficacy of palazestrant (OP-1250) to the standard-of-care options of fulvestrant or an aromatase inhibitor in women and men with breast cancer whose disease has advanced on one endocrine therapy in combination with a CDK4/6 inhibitor.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/23/2025

Locations: Clinical Trial Site, Tucson, Arizona +173 locations

Clinical Trial Site, Tucson, Arizona

Clinical Trial Site, Fountain Valley, California

Clinical Trial Site, La Jolla, California

Clinical Trial Site, Los Angeles, California

Clinical Trial Site, Whittier, California

Clinical Trial Site, Aurora, Colorado

Clinical Trial Site, Denver, Colorado

Clinical Trial Site, Golden, Colorado

Clinical Trial Site, Grand Junction, Colorado

Clinical Trial Site, Danbury, Connecticut

Clinical Trial Site, Newark, Delaware

Clinical Trials Site, Jacksonville, Florida

Clinical Trial Site, Margate, Florida

Clinical Trial Site, Orlando, Florida

Clinical Trial Site, Plantation, Florida

Clinical Trial Site, Tamarac, Florida

Clinical Trial Site, Atlanta, Georgia

Clinical Trial Site, Chicago, Illinois

Clinical Trial Site, Urbana, Illinois

Clinical Trial Site, Baton Rouge, Louisiana

Clinical Trial Site, Baltimore, Maryland

Clinical Trial Site, Boston, Massachusetts

Clinical Trial Site, St Louis Park, Minnesota

Clinical Trial Site, Lincoln, Nebraska

Clinical Trial Site, Farmington, New Mexico

Clinical Trial Site, New York, New York

Clinical Trial Site, Port Jefferson Station, New York

Clinical Trial Site, Dayton, Ohio

Clinical Trial Site, Toledo, Ohio

Clinical Trial Site, Portland, Oregon

Clinical Trial Site, Nashville, Tennessee

Clinical Trial Site, Dallas, Texas

Clinical Trial Site, Houston, Texas

Clinical Trial Site, Spokane, Washington

Clinical Trial Site, San Salvador De Jujuy, Jujuy

Clinical Trial Site, Viedma, Río Negro

Clinical Trial Site, Rosario, Santa Fe

Clinical Trial Site, San Miguel De Tucumán, Tucumán

Clinical Trial Site, Buenos Aires, Not set

Clinical Trial Site, Córdoba, Not set

Clinical Trial Site, La Rioja, Not set

Clinical Trial Site, Gosford, New South Wales

Clinical Trial Site, Westmead, New South Wales

Clinical Trial Site, Adelaide, South Australia

Clinical Trial Site, Ballarat Central, Victoria

Clinical Trial Site, Clayton, Victoria

Clinical Trial Site, Shepparton, Victoria

Clinical Trial Site, Nedlands, Western Australia

Clinical Trial Site, Edegem, Antwerpen

Clinical Trial Site, Woluwe-Saint-Lambert, Brussels

Clinical Trial Site, Charleroi, Hainaut

Clinical Trial Site, Leuven, Vlaams Brabant

Clinical Trial Site, Salvador, Bahia

Clinical Trial Site, Belo Horizonte, Minas Gerais

Clinical Trial Site, Recife, Pernambuco

Clinical Trial Site, Porto Alegre, Rio Grande do Sul

Clinical Trial Site, Itajaí, Santa Catarina

Clinical Trial Site, Sorocaba, São Paulo

Clinical Trial Site, Rio De Janeiro, Not set

Clinical Trial Site, Panagyurishte, Pazardzhik

Clinical Trial Site, Sofia, Sofia-Grad

Clinical Trial Site, Vratsa, Not set

Clinical Trial Site, Calgary, Alberta

Clinical Trial Site, Montréal, Quebec

Clinical Trial Site, Hradec Králové, Královéhradecký kraj

Clinical Trial Site, Nový Jičín, Moravskoslezský kraj

Clinical Trial Site, Olomouc, Olomoucký kraj

Clinical Trial Site, Bourg-en-Bresse, Ain

Clinical Trial Site, Besançon, Doubs

Clinical Trial Site, Nantes, Loire-Atlantique

Clinical Trial Site, Compiègne, Oise

Clinical Trial Site, Clermont-Ferrand, Puy-de-Dôme

Clinical Trial Site, Le Mans, Sarthe

Clinical Trial Site, Villejuif, Val-de-Marne

Clinical Trial Site, Montpellier, Not set

Clinical Trial Site, Karlsruhe, Baden-Württemberg

Clinical Trial Site, Krefeld, Nordrhein-Westfalen

Clinical Trial Site, Velbert, Nordrhein-Westfalen

Clinical Trial Site, Dresden, Sachsen

Clinical Trial Site, Central, Not set

Clinical Trial Site, Hong Kong, Not set

Clinical Trials Site, Hong Kong, Not set

Clinical Trial Site, Kowloon, Not set

Clinical Trial Site, Pécs, Baranya

Clinical Trial Site, Kecskemét, Bács-Kiskun

Clinical Trial Site, Debrecen, Hajdú-Bihar

Clinical Trial Site, Avellino, Campania

Clinical Trial Site, Bologna, Emilia-Romagna

Clinical Trial Site, Meldola, Emilia-Romagna

Clinical Trial Site, Modena, Emilia-Romagna

Clinical Trial Site, Reggio Emilia, Emilia-Romagna

Clinical Trial Site, Udine, Friuli-Venezia Giulia

Clinical Trial Site, Roma, Lazio

Clinical Trial Site, Milano, Lombardia

Clinical Trial Site, Rozzano, Lombardia

Clinical Trial Site, Alessandria, Piemonte

Clinical Trial Site, Pavia, Not set

Clinical Trial Site, Suwon-si, Gyeonggi-do

Clinical Trial Site, Busan, Not set

Clinical Trial Site, Seoul, Not set

Clinical Trial Site, Suwon, Not set

Clinical Trials Site, Sungai Petani, Kedah

Clinical Trial Site, Kota Bharu, Kelantan

Clinical Trial Site, George Town, Penang

Clinical Trial Site, Ipoh, Perak

Clinical Trial Site, Putrajaya, Putramya

Clinical Trial Site, Kuching, Sarawak

Clinical Trial Site, Petaling Jaya, Selangor

Clinical Trial Site, Kuala Lumpur, WP

Clinical Trial Site, Zapopan, Jalisco

Clinical Trial Site, Monterrey, Not set

Clinical Trial Site, Oaxaca, Not set

Clinical Trial Site, Sinaloa, Not set

Clinical Trial Site, Rotterdam, Zuid-Holland

Clinical Trial Site, Łódź, Lódzkie

Clinical Trial Site, Otwock, Mazowieckie

Clinical Trial Site, Brzozów, Podkarpackie

Clinical Trial Site, Rzeszów, Podkarpackie

Clinical Trial Site, Gdynia, Pomorskie

Clinical Trial Site, Skórzewo, Wielkopolskie

Clinical Trial Site, Wrocław, Not set

Clinical Trial Site, Matosinhos, Porto

Clinical Trial Site, Coimbra, Not set

Clinical Trial Site, Lisboa, Not set

Clinical Trial Site, Porto, Not set

Clinical Trial Site, Mayaguez, Not set

Clinical Trial Site, Oradea, Bihor

Clinical Trial Site, București, Bucuresti

Clinical Trial Site, Cluj-Napoca, Cluj

Clinical Trial Site, Craiova, Dolj

Clinical Trial Site, Timisoara, Timis

Clinical Trial Site, Brașov, Not set

Clinical Trial Site, Iași, Not set

Clinical Trial Site, Pamplona, Navarra

Clinical Trial Site, Alicante, Not set

Clinical Trial Site, Badajoz, Not set

Clinical Trial Site, León, Not set

Clinical Trial Site, Lleida, Not set

Clinical Trial Site, Madrid, Not set

Clinical Trial Site, Santiago De Compostela, Not set

Clinical Trial Site, Valencia, Not set

Clinical Trial Site, Changhua, Not set

Clinical Trial Site, Kaohsiung, Not set

Clinical Trial Site, Taichung, Not set

Clinical Trial Site, Tainan City, Not set

Clinical Trial Site, Taipei city, Not set

Clinical Trial Site, Taipei, Not set

Clinical Trial Site, Bangkok, Not set

Clinical Trial Site, Chiang Mai, Not set

Clinical Trial Site, Samut Sakhon, Not set

Clinical Trial Site, Songkhla, Not set

Clinical Trial Site, London, Not set

Conditions: Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma

Learn More ›

KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer

NCT03946202

Recruiting

This is a study aimed at testing a commonly available and inexpensive chemical (hydrogen peroxide) for efficacy in sensitising large cancerous lumps in the breast to a standard course of radiotherapy in patients with locally advanced or recurrent breast cancer. Laboratory research and initial clinical trials in Japan suggest that 4 to 6 injections of a radiation sensitiser ('KORTUC') based on very dilute (0.5%) hydrogen peroxide injected into cancers under local anaesthetic twice a week during r... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/30/2025

Locations: Regional Cancer Centre (RCC), Trivandrum, Kerala +8 locations

Conditions: Breast Cancer

Learn More ›

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

NCT06545942

Recruiting

This Phase 1, multi-center, open-label, dose escalation and dose optimization study is designed to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PDx), and preliminary clinical activity of MOMA-313 administered orally as a single agent or combination therapy in patients with homologous recombinant deficient solid tumors.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/29/2025

Locations: Investigative Site #101, La Jolla, California +14 locations

Conditions: Advanced Solid Tumor, Metastatic Solid Tumor, Prostate Cancer, Pancreas Cancer, Breast Cancer, Ovarian Cancer, Homologous Recombination Deficiency

Learn More ›

13 - 24 of 45